These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 17442842)
1. Rifaximin is a gut-specific human pregnane X receptor activator. Ma X; Shah YM; Guo GL; Wang T; Krausz KW; Idle JR; Gonzalez FJ J Pharmacol Exp Ther; 2007 Jul; 322(1):391-8. PubMed ID: 17442842 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. Cheng J; Shah YM; Ma X; Pang X; Tanaka T; Kodama T; Krausz KW; Gonzalez FJ J Pharmacol Exp Ther; 2010 Oct; 335(1):32-41. PubMed ID: 20627999 [TBL] [Abstract][Full Text] [Related]
3. A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4. Ma X; Cheung C; Krausz KW; Shah YM; Wang T; Idle JR; Gonzalez FJ Drug Metab Dispos; 2008 Dec; 36(12):2506-12. PubMed ID: 18799805 [TBL] [Abstract][Full Text] [Related]
4. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis. Terc J; Hansen A; Alston L; Hirota SA Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481 [TBL] [Abstract][Full Text] [Related]
6. EFFECT OF PREGNANE XENOBIOTIC RECEPTOR ACTIVATION ON INFLAMMATORY BOWEL DISEASE TREATED WITH RIFAXIMIN. Wan YC; Li T; Han YD; Zhang HY; Lin H; Zhang B J Biol Regul Homeost Agents; 2015; 29(2):401-10. PubMed ID: 26122229 [TBL] [Abstract][Full Text] [Related]
8. Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells. Mencarelli A; Migliorati M; Barbanti M; Cipriani S; Palladino G; Distrutti E; Renga B; Fiorucci S Biochem Pharmacol; 2010 Dec; 80(11):1700-7. PubMed ID: 20816942 [TBL] [Abstract][Full Text] [Related]
9. A human and mouse pregnane X receptor reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific CYP3A induction. Vignati LA; Bogni A; Grossi P; Monshouwer M Toxicology; 2004 Jun; 199(1):23-33. PubMed ID: 15125996 [TBL] [Abstract][Full Text] [Related]
10. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression. Li T; Chiang JY Drug Metab Dispos; 2006 May; 34(5):756-64. PubMed ID: 16455805 [TBL] [Abstract][Full Text] [Related]
11. Activation of intestinal human pregnane X receptor protects against azoxymethane/dextran sulfate sodium-induced colon cancer. Cheng J; Fang ZZ; Nagaoka K; Okamoto M; Qu A; Tanaka N; Kimura S; Gonzalez FJ J Pharmacol Exp Ther; 2014 Dec; 351(3):559-67. PubMed ID: 25277138 [TBL] [Abstract][Full Text] [Related]
12. CYP3A4 Induction in the Liver and Intestine of Pregnane X Receptor/CYP3A-Humanized Mice: Approaches by Mass Spectrometry Imaging and Portal Blood Analysis. Kobayashi K; Kuze J; Abe S; Takehara S; Minegishi G; Igarashi K; Kitajima S; Kanno J; Yamamoto T; Oshimura M; Kazuki Y Mol Pharmacol; 2019 Nov; 96(5):600-608. PubMed ID: 31455676 [TBL] [Abstract][Full Text] [Related]
13. The PREgnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A. Ma X; Shah Y; Cheung C; Guo GL; Feigenbaum L; Krausz KW; Idle JR; Gonzalez FJ Drug Metab Dispos; 2007 Feb; 35(2):194-200. PubMed ID: 17093002 [TBL] [Abstract][Full Text] [Related]
14. Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. Ripp SL; Fitzpatrick JL; Peters JM; Prough RA Drug Metab Dispos; 2002 May; 30(5):570-5. PubMed ID: 11950789 [TBL] [Abstract][Full Text] [Related]
15. The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor. Ding X; Lichti K; Staudinger JL Toxicol Sci; 2006 Jun; 91(2):448-55. PubMed ID: 16547076 [TBL] [Abstract][Full Text] [Related]
16. Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region. Koyano S; Kurose K; Saito Y; Ozawa S; Hasegawa R; Komamura K; Ueno K; Kamakura S; Kitakaze M; Nakajima T; Matsumoto K; Akasawa A; Saito H; Sawada J Drug Metab Dispos; 2004 Jan; 32(1):149-54. PubMed ID: 14709632 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. Johnson CH; Bonzo JA; Cheng J; Krausz KW; Kang DW; Luecke H; Idle JR; Gonzalez FJ Drug Metab Dispos; 2013 Feb; 41(2):406-13. PubMed ID: 23160821 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells. Mencarelli A; Renga B; Palladino G; Claudio D; Ricci P; Distrutti E; Barbanti M; Baldelli F; Fiorucci S Eur J Pharmacol; 2011 Oct; 668(1-2):317-24. PubMed ID: 21806984 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. Faucette SR; Sueyoshi T; Smith CM; Negishi M; Lecluyse EL; Wang H J Pharmacol Exp Ther; 2006 Jun; 317(3):1200-9. PubMed ID: 16513849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]